US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Verve Therapeutics

6.20

+0.46508.12%

Post-market: 6.17-0.0250-0.40%19:55 EDT

Volume:4.67M

Turnover:29.06M

Market Cap:552.24M

PE:-2.95

High:6.58

Open:5.85

Low:5.77

Close:5.73

Loading ...

Overview Company News Filings

Cantor upgrades Verve Therapeutics to Overweight after positive data

Verve Therapeutics upgraded to Overweight from Neutral at Cantor Fitzgerald

U.S. RESEARCH ROUNDUP- CNB Financial, Disney, Triumph Group

Verve Therapeutics Is Maintained at Buy by HC Wainwright & Co.

This Cholesterol Gene Medicine Could Work in 1 Shot. It Could Also Bring This Biotech Stock Back to Life. -- Barrons.com

Verve Therapeutics price target raised to $25 from $15 at H.C. Wainwright

Verve Therapeutics, Inc. : H.c. Wainwright Raises Target Price to $25 From $15

THOMSON REUTERS

Verve Shares Soar 21% After New Gene-Editing Trial Shows No Safety Concerns

Top Premarket Gainers

MT Newswires Live

Verve Therapeutics Shares up 22.7% at $4 Premarket After Initial Early-Stage Data for Gene Editing Therapy

THOMSON REUTERS

Verve Therapeutics' VERVE-102 Gene Editing Therapy Trial Shows Positive Initial Data in Clinical Trial

MT Newswires Live

Verve Therapeutics Surges Premarket on Verve-102 Study Data

Buy Rating for Verve Therapeutics: Promising Safety and Efficacy of VERVE-102 in Phase 1b Heart-2 Study

Verve announces initial data from Heart-2 Phase 1b trial of VERVE-102

Verve Therapeutics- Verve-102, No Clinically Significant Changes in Alt or Platelets Observed at Any Dose Level Among 14 Participants

THOMSON REUTERS

Verve Therapeutics Announces Positive Initial Data from the Heart-2 Phase 1b Clinical Trial of VERVE-102, an In Vivo Base Editing Medicine Targeting PCSK9

Verve Therapeutics Gets FDA Fast Track Designation for VERVE-102

MT Newswires Live

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Biotech stocks slide as Marks resignation seen being negative for sector

Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/VERV/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VERV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VERV\",,,,,undefined,":{"symbol":"VERV","market":"US","secType":"STK","nameCN":"Verve Therapeutics","latestPrice":6.195,"timestamp":1749240000000,"preClose":5.73,"halted":0,"volume":4674554,"hourTrading":{"tag":"盘后","latestPrice":6.17,"preClose":6.195,"latestTime":"19:55 EDT","volume":31885,"amount":197094.8936,"timestamp":1749254137656},"delay":0,"floatShares":65317335,"shares":89143237,"eps":-2.101349,"marketStatus":"Market Closed","change":0.465,"latestTime":"06-06 16:00:00 EDT","open":5.85,"high":6.58,"low":5.772,"amount":29058006.515607603,"amplitude":0.141012,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.101349,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749456000000},"marketStatusCode":7,"adr":0,"listingDate":1623902400000,"exchange":"NASDAQ","adjPreClose":5.73,"preHourTrading":{"tag":"盘前","latestPrice":5.82,"preClose":5.73,"latestTime":"09:27 EDT","volume":29510,"amount":174989.540037,"timestamp":1749216470016},"postHourTrading":{"tag":"盘后","latestPrice":6.17,"preClose":6.195,"latestTime":"19:55 EDT","volume":31885,"amount":197094.8936,"timestamp":1749254137656},"volumeRatio":1.2161220890001858,"impliedVol":1.2111,"impliedVolPercentile":0.608},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VERV\",,,,,undefined,":{"symbol":"VERV","floatShares":65317335,"roa":"-19.35%","roe":"-34.26%","lyrEps":-2.345416,"volumeRatio":1.2161220890001858,"shares":89143237,"dividePrice":0,"high":6.58,"amplitude":0.141012,"preClose":5.73,"low":5.772,"week52Low":2.8647,"pbRate":"1.17","psRate":"9.26","week52High":9.305,"institutionHeld":0,"latestPrice":6.195,"eps":-2.101349,"divideRate":0,"volume":4674554,"delay":0,"ttmEps":-2.101349,"open":5.85,"prevYearClose":5.64,"prevWeekClose":4.45,"prevMonthClose":4.45,"prevQuarterClose":4.57,"fiveDayClose":4.45,"twentyDayClose":4.48,"sixtyDayClose":6.42},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VERV\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2527499636","title":"Cantor upgrades Verve Therapeutics to Overweight after positive data","url":"https://stock-news.laohu8.com/highlight/detail?id=2527499636","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527499636?lang=en_us&edition=fundamental","pubTime":"2025-04-15 18:54","pubTimestamp":1744714442,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald upgraded Verve Therapeutics (VERV) to Overweight from Neutral without a price target following the initial Heart-2 Phase 1 data. ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cantor-upgrades-verve-therapeutics-to-overweight-after-positive-data?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cantor-upgrades-verve-therapeutics-to-overweight-after-positive-data?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VERV"],"gpt_icon":0},{"id":"2527498294","title":"Verve Therapeutics upgraded to Overweight from Neutral at Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2527498294","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527498294?lang=en_us&edition=fundamental","pubTime":"2025-04-15 18:10","pubTimestamp":1744711833,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald upgraded Verve Therapeutics (VERV) to Overweight from Neutral. Published first on TheFly – the ultimate source for real-time, mar...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/verve-therapeutics-upgraded-to-overweight-from-neutral-at-cantor-fitzgerald?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/verve-therapeutics-upgraded-to-overweight-from-neutral-at-cantor-fitzgerald?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VERV"],"gpt_icon":0},{"id":"2527345580","title":"U.S. RESEARCH ROUNDUP- CNB Financial, Disney, Triumph Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2527345580","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527345580?lang=en_us&edition=fundamental","pubTime":"2025-04-15 15:16","pubTimestamp":1744701380,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP- CNB Financial, Disney, Triumph Group April 15 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including CNB","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nL4N3QT0KA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1551013342.USD","LU1974910355.USD","NEE","IE00BBT3K403.USD","GKOS","IE0004091025.USD","LU1934455863.HKD","TGI","RLYB","RXST","IRWD","BK4599","LU2237443382.USD","IE00BGHQF417.EUR","BK4550","PRU","NWFL","BAH","IAC","SAIC","KNTK","SCHW","RDFN","BK4527","LU1978683503.SGD","TPG","LU2237443895.HKD","LU0661504455.SGD","GIS","FI","GPN","OKE","VERV","BX","LU1868836914.USD","CCNE","CMG","CG","LU0511384066.AUD","ANGI","ARES","CERT","CNP","MTB","DIS","DUK","IE00B64PRP62.GBP","NOW"],"gpt_icon":1},{"id":"2527119436","title":"Verve Therapeutics Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2527119436","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527119436?lang=en_us&edition=fundamental","pubTime":"2025-04-15 01:46","pubTimestamp":1744652760,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/VERV/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 14, 2025 13:46 ET (17:46 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VERV"],"gpt_icon":0},{"id":"2527116967","title":"This Cholesterol Gene Medicine Could Work in 1 Shot. It Could Also Bring This Biotech Stock Back to Life. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2527116967","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527116967?lang=en_us&edition=fundamental","pubTime":"2025-04-15 01:27","pubTimestamp":1744651620,"startTime":"0","endTime":"0","summary":"A single infusion of a Verve Therapeutics gene-editing treatment cut dangerously high levels of cholesterol in a group of patients by more than half. The company reported Monday that cholesterol levels fell by 59% in the first month, with no significant side effects, for patients getting the high dose.There were 14 patients in Verve's Phase 1 trail, which it called Heart-2. Higher doses of its genetic medicine led to deeper cuts in the harmful form of cholesterol known as LDL-C.\"These initial Heart-2 data are promising with respect to both safety and efficacy and suggest the potential for a new era of cardiovascular disease treatment where a single dose might lead to lifelong control of LDL-C,\" said Harvard Medical School professor Eugene Braunwald, in Verve's press release.As with many firms developing therapies, Verve is testing its PCSK9 editor on the sickest patients fi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BK4W5L77.USD","LU2237443622.USD","LU1023059063.AUD","LU2361045086.USD","NVS","LU1917777945.USD","LU0238689110.USD","LU2264538146.SGD","LU1983299246.USD","LU2357305700.SGD","REGN","LU1804176565.USD","IE00B1BXHZ80.USD","IE0002141913.USD","LU1366192091.USD","LU0820561818.USD","SG9999014906.USD","LU2237443895.HKD","IE0009355771.USD","LU1291159041.SGD","SGXZ81514606.USD","LU0320765992.SGD","LU0640476718.USD","SG9999015978.USD","SG9999001176.SGD","LU0094547139.USD","LU0203202063.USD","LU1868836757.USD","LU1814569148.SGD","BK4578","SG9999014880.SGD","LU0385154629.USD","LU1069344957.HKD","LU0417517546.SGD","LU2106854487.HKD","LU2112291526.USD","LU1988902786.USD","LU1623119135.USD","SG9999015945.SGD","AMGN","VERV","LU2089984988.USD","LU1064131342.USD","LU0006306889.USD","BK4532","LU0354030511.USD","IE00B2B36J28.USD","LU1551013342.USD","BK4539"],"gpt_icon":1},{"id":"2527190976","title":"Verve Therapeutics price target raised to $25 from $15 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2527190976","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527190976?lang=en_us&edition=fundamental","pubTime":"2025-04-15 00:10","pubTimestamp":1744647041,"startTime":"0","endTime":"0","summary":"H.C. Wainwright raised the firm’s price target on Verve Therapeutics (VERV) to $25 from $15 and keeps a Buy rating on the shares after the company ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/verve-therapeutics-price-target-raised-to-25-from-15-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/verve-therapeutics-price-target-raised-to-25-from-15-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VERV"],"gpt_icon":0},{"id":"2527629197","title":"Verve Therapeutics, Inc. : H.c. Wainwright Raises Target Price to $25 From $15","url":"https://stock-news.laohu8.com/highlight/detail?id=2527629197","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527629197?lang=en_us&edition=fundamental","pubTime":"2025-04-15 00:02","pubTimestamp":1744646569,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nAZN3P5JHU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","VERV"],"gpt_icon":0},{"id":"1144848113","title":"Verve Shares Soar 21% After New Gene-Editing Trial Shows No Safety Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=1144848113","media":"Bloomberg","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144848113?lang=en_us&edition=fundamental","pubTime":"2025-04-14 22:44","pubTimestamp":1744641880,"startTime":"0","endTime":"0","summary":"$Verve Therapeutics Inc.$ shares jumped 21% after the company reported no safety issues in a new study of its gene-editing treatment for people with high cholesterol.The Boston-based company said its treatment was well-tolerated with no serious treatment-related adverse events among 14 participants in an early-stage trial. The treatment led to an average reduction in cholesterol of 53% in patients who received the highest dose, according to a statement.In a note to clients Monday, William Blair ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bloomberg.com/news/articles/2025-04-14/verve-shares-soar-after-new-trial-shows-no-safety-concerns","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lsy1584095487587","symbols":["VERV"],"gpt_icon":1},{"id":"2527268163","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2527268163","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527268163?lang=en_us&edition=fundamental","pubTime":"2025-04-14 20:48","pubTimestamp":1744634935,"startTime":"0","endTime":"0","summary":"Third Harmonic Bio (THRD) shares rose 40% in recent Monday premarket activity, after saying its board has approved a plan for the company's liquidation and dissolution and will seek stockholder approv","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["VERV","LU1261432733.SGD","LU2065170008.USD","LU0345770308.USD","LU0256863902.USD","THRD","LU0345768740.USD","LU0553294199.USD","LU1244550494.USD","LU1267930730.SGD","SG9999014898.SGD","SG9999017495.SGD","LU0096362180.USD","LU2191332357.HKD","PTN","LU0316494557.USD","PTN.AU","LU0256863811.USD","LU1582986359.USD","IE00BKVL7J92.USD","BK4507","LU1699723380.USD","LU2543165471.USD","BK4550","SG9999014542.SGD","LU2602419157.SGD","LU1066053197.SGD","LU1280957306.USD","LU0868494617.USD","LU0979878070.USD","IE0004445239.USD","LU1814569148.SGD","IE00B19Z8X17.USD","LU0048584097.USD","HK0000306685.HKD","LU1674673428.USD","SG9999014575.USD","BK4592","LU0314104364.USD","IE0009356076.USD","BP","IE000YTNTUN2.SGD","LU2462157665.USD","LU0672654240.SGD","LU2357305700.SGD","BK4007","LU0889565833.HKD","MACW.SI","LU0957791311.USD"],"gpt_icon":1},{"id":"2527152057","title":"Verve Therapeutics Shares up 22.7% at $4 Premarket After Initial Early-Stage Data for Gene Editing Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2527152057","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527152057?lang=en_us&edition=fundamental","pubTime":"2025-04-14 20:18","pubTimestamp":1744633117,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nFWN3QQ05I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VERV","BK4539"],"gpt_icon":0},{"id":"2527152911","title":"Verve Therapeutics' VERVE-102 Gene Editing Therapy Trial Shows Positive Initial Data in Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2527152911","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527152911?lang=en_us&edition=fundamental","pubTime":"2025-04-14 20:13","pubTimestamp":1744632783,"startTime":"0","endTime":"0","summary":"Verve Therapeutics (VERV) reported Monday positive initial results from its phase 1b Heart-2 clinical trial evaluating VERVE-102, a gene editing therapy for patients with heterozygous familial hyperch","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["VERV","BK4539","BK4139"],"gpt_icon":0},{"id":"2527773152","title":"Verve Therapeutics Surges Premarket on Verve-102 Study Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2527773152","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527773152?lang=en_us&edition=fundamental","pubTime":"2025-04-14 20:08","pubTimestamp":1744632480,"startTime":"0","endTime":"0","summary":"Verve Therapeutics shares rose sharply in premarket trading Monday after the clinical-stage genetic-medicines company reported positive early study data for its Verve-102 gene-editing drug targeting a cholesterol driver of atherosclerosis.Shares of the Boston company, which closed Friday at $3.26, were recently up 45% to $4.74.Verve-102 is designed to be a single-course treatment that permanently turns off the PCSK9 gene in the liver and durably reduces low-density lipoprotein cholesterol, or LDL-C.Verve said a single infusion of Verve-102 led to dose-dependent decreases in blood PCSK9 protein levels and LDL-C, with a mean reduction in blood LDL-C of 53% and a maximum LDL-C reduction of 69% observed among four participants in the 0.6 mg/kg dose cohort.Verve on Friday said the U.S. Food and Drug Administration granted fast-track designation to Verve-102.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","VERV"],"gpt_icon":0},{"id":"2527154874","title":"Buy Rating for Verve Therapeutics: Promising Safety and Efficacy of VERVE-102 in Phase 1b Heart-2 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2527154874","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527154874?lang=en_us&edition=fundamental","pubTime":"2025-04-14 19:45","pubTimestamp":1744631137,"startTime":"0","endTime":"0","summary":"Verve Therapeutics (VERV – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Cory Jubinville, ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-for-verve-therapeutics-promising-safety-and-efficacy-of-verve-102-in-phase-1b-heart-2-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-for-verve-therapeutics-promising-safety-and-efficacy-of-verve-102-in-phase-1b-heart-2-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VERV"],"gpt_icon":0},{"id":"2527045153","title":"Verve announces initial data from Heart-2 Phase 1b trial of VERVE-102","url":"https://stock-news.laohu8.com/highlight/detail?id=2527045153","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527045153?lang=en_us&edition=fundamental","pubTime":"2025-04-14 19:11","pubTimestamp":1744629103,"startTime":"0","endTime":"0","summary":"Verve Therapeutics (VERV) announced initial data from the Heart-2 Phase 1b clinical trial of VERVE-102. The Heart-2 Phase 1b clinical trial is eval...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/verve-announces-initial-data-from-heart-2-phase-1b-trial-of-verve-102?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/verve-announces-initial-data-from-heart-2-phase-1b-trial-of-verve-102?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","VERV"],"gpt_icon":0},{"id":"2527563158","title":"Verve Therapeutics- Verve-102, No Clinically Significant Changes in Alt or Platelets Observed at Any Dose Level Among 14 Participants","url":"https://stock-news.laohu8.com/highlight/detail?id=2527563158","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527563158?lang=en_us&edition=fundamental","pubTime":"2025-04-14 19:00","pubTimestamp":1744628409,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nFWN3QQ054:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VERV","BK4539","BK4139"],"gpt_icon":0},{"id":"2527533581","title":"Verve Therapeutics Announces Positive Initial Data from the Heart-2 Phase 1b Clinical Trial of VERVE-102, an In Vivo Base Editing Medicine Targeting PCSK9","url":"https://stock-news.laohu8.com/highlight/detail?id=2527533581","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527533581?lang=en_us&edition=fundamental","pubTime":"2025-04-14 19:00","pubTimestamp":1744628400,"startTime":"0","endTime":"0","summary":"Single infusion of VERVE-102 led to dose-dependent decreases in blood PCSK9 and LDL-C, with mean reduction in LDL-C of 53% and a maximum reduction of 69% observed in the 0.6 mg/kg dose cohort VERVE-10","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/14/3060774/0/en/Verve-Therapeutics-Announces-Positive-Initial-Data-from-the-Heart-2-Phase-1b-Clinical-Trial-of-VERVE-102-an-In-Vivo-Base-Editing-Medicine-Targeting-PCSK9.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","BK4539","BK4505","BK4139","BK4599","PD","VERV","LU1169590202.USD","BK4588","LU1169589451.USD","BK4585","RNA","ALT","LU1878469433.USD"],"gpt_icon":0},{"id":"2526668852","title":"Verve Therapeutics Gets FDA Fast Track Designation for VERVE-102","url":"https://stock-news.laohu8.com/highlight/detail?id=2526668852","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526668852?lang=en_us&edition=fundamental","pubTime":"2025-04-11 19:40","pubTimestamp":1744371630,"startTime":"0","endTime":"0","summary":"Verve Therapeutics  said Friday the US Food and Drug Administration granted fast track designation for its experimental VERVE-102 treatment for hyperlipidemia and high lifetime cardiovascular risk to lower low-density lipoprotein cholesterol.The company is testing VERVE-102 in a phase 1b clinical trial. The study's demographic and initial safety and efficacy data are expected in Q2.Verve Therapeutics shares were up 4.9% in recent premarket activity.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FAST","BK4585","VERV","IE00BFXG0V08.USD","BK4104","BK4539","BK4588","IE00BYQQ9H92.USD","BK4139","BK4567","IE00B5TLWC47.USD"],"gpt_icon":0},{"id":"2525499737","title":"Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2525499737","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525499737?lang=en_us&edition=fundamental","pubTime":"2025-04-05 04:05","pubTimestamp":1743797100,"startTime":"0","endTime":"0","summary":"BOSTON, April  04, 2025  (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on March 31, 2025","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/04/3056189/0/en/Verve-Therapeutics-Announces-Inducement-Grants-under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USJW.SI","VERV","PSQ","IE00B3QW5Z07.USD","BK4112","BK4539","MNQmain","LU2210149790.SGD","SQQQ","USAW.SI","LU2095319765.USD","IE00B64PRP62.GBP","BK4585","IE00BGHQF748.EUR","NQmain","BK4588","NVIW.SI",".IXIC","QID","TSYW.SI","BK4139","QLD","LU2210150020.SGD","IE00BKPKM429.USD","NDAQ","TQQQ"],"gpt_icon":1},{"id":"2524491531","title":"Biotech stocks slide as Marks resignation seen being negative for sector","url":"https://stock-news.laohu8.com/highlight/detail?id=2524491531","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524491531?lang=en_us&edition=fundamental","pubTime":"2025-04-01 23:50","pubTimestamp":1743522637,"startTime":"0","endTime":"0","summary":"Shares of several biotech and biopharma names are under pressure on Monday following the resignation of the head of the Food and Drug Administration’s Center for Biologics Evaluation and Research, Peter Marks. RBC Capital says the development is “not good for the biotech industry even beyond vaccines.” Voicing a similar opinion, BMO Capital told investors this morning that it sees the news as a “significant negative” for the biopharma and biotech sectors.Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks.“NOT GOOD” FOR BIOTECH SECTOR: RBC Capital believes the resignation of the head of the FDA’s Center for Biologics Evaluation and Research, Peter Marks, is “not good for the biotech industry even beyond vaccines.” Marks had been a key advocate for more flexible, efficient approval processes for drugs, particularly those for orphan diseases such as gene therapies, the firm tells investors in a research note.PRICE ACTION: In mornin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/biotech-stocks-slide-marks-resignation-155037694.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biotech-stocks-slide-marks-resignation-155037694.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1066051498.USD","LU2362540622.SGD","BK4139","SRPT","MGTX","LU1069344957.HKD","REGN","LU0058720904.USD","DYN","IE00BFTCPJ56.SGD","BEAM","IE00B4R5TH58.HKD","RCKT","LU2023250504.SGD","IE0009355771.USD","IE00BZ9MQY76.HKD","RGNX","BK4551","VRTX","LU2462157665.USD","IE00B3T34201.USD","TSHA","GILD","LU2468319806.SGD","BK4007","VERV","LU1571399168.USD","MRNA","RNA","DTIL","LU1035775433.USD","BK4578","CRSP","LU0320765992.SGD","GLPG","RCKTW","LEGN","IE0002141913.USD","PTCT","BK4532","LU1430594728.SGD","LU1066053197.SGD","MGX","KPTI","PCRX","FDMT","LU0823416689.USD","BK4568","NTLA","PRME","NGNE","LU0417517546.SGD"],"gpt_icon":1},{"id":"2524191062","title":"Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2524191062","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524191062?lang=en_us&edition=fundamental","pubTime":"2025-04-01 19:00","pubTimestamp":1743505202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nTUA7FW8VJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK7508","CLYM","BK4139","LENZ","BK7067","VERV","IMU.AU","ABOS","SLDB"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":72,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VERV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-08-12","symbol":"VERV","fiscalQuarterEnding":"2021/06","expectedEps":-0.53,"name":null,"time":"","type":"earning","dateTimestamp":1628740800000,"reportTimeType":"","actualEps":-2.13}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VERV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VERV\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3,"buy":0.6,"hold":0.1,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":10,"updateTime":1744776000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VERV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VERV","date":"2025-06-06","current":-2.821955,"percent":0.765803,"low":-62.162259,"twenty":-14.591567,"median":-5.970002,"eighty":-2.670721,"high":-1.327184,"avg":-9.71957,"sd":10.281407,"marketCap":510790748},"quantilePoints":[{"date":"2021-06-18","current":-32.654395,"twenty":-29.497947,"median":-21.167295,"eighty":-14.940941,"marketCap":1742569153},{"date":"2021-06-25","current":-32.306422,"twenty":-33.28127,"median":-32.654395,"eighty":-22.412565,"marketCap":1723999890},{"date":"2021-07-02","current":-45.008169,"twenty":-46.085349,"median":-33.298325,"eighty":-30.341312,"marketCap":2401815906},{"date":"2021-07-09","current":-41.291898,"twenty":-44.182331,"median":-37.719251,"eighty":-32.445611,"marketCap":2203500832},{"date":"2021-07-16","current":-43.598858,"twenty":-44.860954,"median":-41.51631,"eighty":-32.65883,"marketCap":2326609465},{"date":"2021-07-23","current":-46.938116,"twenty":-46.880666,"median":-42.889715,"eighty":-32.884508,"marketCap":2504805619},{"date":"2021-07-30","current":-53.347337,"twenty":-47.706504,"median":-43.598858,"eighty":-33.28127,"marketCap":2846827270},{"date":"2021-08-06","current":-61.112009,"twenty":-51.440728,"median":-44.909427,"eighty":-34.047863,"marketCap":3261181231},{"date":"2021-08-13","current":-29.159869,"twenty":-53.788981,"median":-45.008169,"eighty":-33.28127,"marketCap":2879507940},{"date":"2021-08-20","current":-30.768522,"twenty":-53.002639,"median":-44.119495,"eighty":-31.587801,"marketCap":3038360794},{"date":"2021-08-27","current":-34.180227,"twenty":-51.440728,"median":-42.943574,"eighty":-31.289512,"marketCap":3375263223},{"date":"2021-09-03","current":-34.695385,"twenty":-49.403063,"median":-41.704816,"eighty":-31.582083,"marketCap":3426134530},{"date":"2021-09-10","current":-35.958979,"twenty":-48.686738,"median":-40.843073,"eighty":-31.68803,"marketCap":3550913208},{"date":"2021-09-17","current":-29.10155,"twenty":-48.45694,"median":-35.6042,"eighty":-31.158293,"marketCap":2873748924},{"date":"2021-09-24","current":-23.293876,"twenty":-47.7083,"median":-34.712395,"eighty":-30.238785,"marketCap":2300246926},{"date":"2021-10-01","current":-24.110352,"twenty":-47.589809,"median":-34.243407,"eighty":-29.159869,"marketCap":2380873148},{"date":"2021-10-08","current":-21.354744,"twenty":-47.103283,"median":-34.027137,"eighty":-25.692351,"marketCap":2108759648},{"date":"2021-10-15","current":-21.349884,"twenty":-46.909391,"median":-33.383602,"eighty":-24.247403,"marketCap":2108279730},{"date":"2021-10-22","current":-20.761827,"twenty":-46.605986,"median":-32.917417,"eighty":-23.323036,"marketCap":2050209653},{"date":"2021-10-29","current":-22.545439,"twenty":-45.812463,"median":-32.306422,"eighty":-22.932294,"marketCap":2226339555},{"date":"2021-11-05","current":-26.136963,"twenty":-45.525215,"median":-31.587429,"eighty":-23.25694,"marketCap":2580998950},{"date":"2021-11-12","current":-20.667105,"twenty":-44.968672,"median":-31.108721,"eighty":-22.843842,"marketCap":2325214652},{"date":"2021-11-19","current":-17.682856,"twenty":-44.776575,"median":-30.600853,"eighty":-22.274252,"marketCap":1989462713},{"date":"2021-11-26","current":-14.193382,"twenty":-44.640132,"median":-30.158595,"eighty":-21.777562,"marketCap":1596868981},{"date":"2021-12-03","current":-13.675313,"twenty":-43.598858,"median":-29.159869,"eighty":-21.369324,"marketCap":1538582059},{"date":"2021-12-10","current":-13.983585,"twenty":-43.266728,"median":-28.931451,"eighty":-21.087446,"marketCap":1573265186},{"date":"2021-12-17","current":-16.813698,"twenty":-42.943574,"median":-26.642401,"eighty":-20.667105,"marketCap":1891675562},{"date":"2021-12-23","current":-17.691419,"twenty":-42.8574,"median":-26.136963,"eighty":-17.715396,"marketCap":1990426133},{"date":"2021-12-31","current":-15.786123,"twenty":-42.08183,"median":-25.274317,"eighty":-17.274395,"marketCap":1776065138},{"date":"2022-01-07","current":-13.72241,"twenty":-41.591713,"median":-24.46513,"eighty":-16.775164,"marketCap":1543880870},{"date":"2022-01-14","current":-14.039245,"twenty":-41.33678,"median":-24.246431,"eighty":-15.710768,"marketCap":1579527417},{"date":"2022-01-21","current":-13.923643,"twenty":-40.753308,"median":-24.188111,"eighty":-15.395644,"marketCap":1566521245},{"date":"2022-01-28","current":-12.176765,"twenty":-37.733087,"median":-23.439675,"eighty":-14.983072,"marketCap":1369983524},{"date":"2022-02-04","current":-11.551657,"twenty":-35.746112,"median":-23.279296,"eighty":-14.684049,"marketCap":1299653849},{"date":"2022-02-11","current":-13.247156,"twenty":-35.268232,"median":-22.851618,"eighty":-14.251611,"marketCap":1490411049},{"date":"2022-02-18","current":-11.457463,"twenty":-34.855344,"median":-22.538149,"eighty":-14.189957,"marketCap":1289056227},{"date":"2022-02-25","current":-13.170088,"twenty":-34.715796,"median":-22.29758,"eighty":-14.064935,"marketCap":1481740267},{"date":"2022-03-04","current":-11.838522,"twenty":-34.561249,"median":-22.030281,"eighty":-13.877402,"marketCap":1331928426},{"date":"2022-03-11","current":-11.247666,"twenty":-34.31339,"median":-21.692513,"eighty":-13.701858,"marketCap":1265452432},{"date":"2022-03-18","current":-10.085637,"twenty":-34.218135,"median":-21.369324,"eighty":-13.587969,"marketCap":1213443343},{"date":"2022-03-25","current":-9.443677,"twenty":-34.129683,"median":-21.228995,"eighty":-13.23945,"marketCap":1136206557},{"date":"2022-04-01","current":-9.088378,"twenty":-34.032483,"median":-20.922206,"eighty":-13.160668,"marketCap":1093459153},{"date":"2022-04-08","current":-7.917508,"twenty":-33.982912,"median":-20.714466,"eighty":-12.679421,"marketCap":952587027},{"date":"2022-04-14","current":-8.208207,"twenty":-33.842055,"median":-19.47469,"eighty":-12.374573,"marketCap":987562176},{"date":"2022-04-22","current":-6.665887,"twenty":-33.349491,"median":-17.691419,"eighty":-12.192179,"marketCap":801999583},{"date":"2022-04-29","current":-6.034246,"twenty":-33.204309,"median":-17.492326,"eighty":-11.914733,"marketCap":726004260},{"date":"2022-05-06","current":-5.334565,"twenty":-33.068577,"median":-16.852232,"eighty":-11.563646,"marketCap":641822801},{"date":"2022-05-13","current":-4.869088,"twenty":-32.663265,"median":-16.76232,"eighty":-11.392383,"marketCap":668121653},{"date":"2022-05-20","current":-4.755606,"twenty":-32.5848,"median":-16.150056,"eighty":-10.105824,"marketCap":652549990},{"date":"2022-05-27","current":-5.54998,"twenty":-32.241841,"median":-15.409346,"eighty":-9.616481,"marketCap":761551629},{"date":"2022-06-03","current":-5.170525,"twenty":-31.983517,"median":-15.39436,"eighty":-9.354852,"marketCap":709483882},{"date":"2022-06-10","current":-4.471901,"twenty":-31.614158,"median":-15.302306,"eighty":-9.088378,"marketCap":613620834},{"date":"2022-06-17","current":-4.486086,"twenty":-31.560699,"median":-14.940941,"eighty":-8.446418,"marketCap":615567291},{"date":"2022-06-24","current":-5.993269,"twenty":-31.397404,"median":-14.839897,"eighty":-8.028942,"marketCap":822378437},{"date":"2022-07-01","current":-5.542888,"twenty":-31.158293,"median":-14.347518,"eighty":-7.642151,"marketCap":760578400},{"date":"2022-07-08","current":-7.528823,"twenty":-30.94251,"median":-14.261887,"eighty":-7.437047,"marketCap":1033082498},{"date":"2022-07-15","current":-8.408309,"twenty":-30.793794,"median":-14.208367,"eighty":-7.437047,"marketCap":1153762884},{"date":"2022-07-22","current":-12.715115,"twenty":-30.567319,"median":-14.184819,"eighty":-7.498573,"marketCap":1744729900},{"date":"2022-07-29","current":-10.451203,"twenty":-30.287385,"median":-14.071357,"eighty":-7.594882,"marketCap":1434082747},{"date":"2022-08-05","current":-11.321429,"twenty":-30.152277,"median":-13.979303,"eighty":-7.641344,"marketCap":1553492562},{"date":"2022-08-12","current":-17.039792,"twenty":-29.572967,"median":-13.981444,"eighty":-7.645381,"marketCap":2133347845},{"date":"2022-08-19","current":-16.029565,"twenty":-29.177365,"median":-14.103469,"eighty":-7.782487,"marketCap":2006869509},{"date":"2022-08-26","current":-18.777764,"twenty":-29.159869,"median":-14.1891,"eighty":-7.899631,"marketCap":2350938535},{"date":"2022-09-02","current":-17.595177,"twenty":-29.124878,"median":-14.210508,"eighty":-7.970802,"marketCap":2202880958},{"date":"2022-09-09","current":-18.552738,"twenty":-28.96547,"median":-14.261887,"eighty":-8.017637,"marketCap":2322765636},{"date":"2022-09-16","current":-17.499421,"twenty":-28.21427,"median":-14.469542,"eighty":-8.09758,"marketCap":2190892490},{"date":"2022-09-23","current":-16.854037,"twenty":-27.093149,"median":-14.934092,"eighty":-8.198517,"marketCap":2110091673},{"date":"2022-09-30","current":-16.498608,"twenty":-26.578249,"median":-14.95128,"eighty":-8.288248,"marketCap":2065592732},{"date":"2022-10-07","current":-16.090346,"twenty":-26.343998,"median":-15.287456,"eighty":-8.423553,"marketCap":2014479084},{"date":"2022-10-14","current":-14.678238,"twenty":-25.973668,"median":-15.294881,"eighty":-8.459338,"marketCap":1837685994},{"date":"2022-10-21","current":-15.369882,"twenty":-25.549878,"median":-15.302306,"eighty":-8.480333,"marketCap":1924278528},{"date":"2022-10-28","current":-19.548569,"twenty":-25.275775,"median":-15.343465,"eighty":-8.522485,"marketCap":2447441752},{"date":"2022-11-04","current":-15.028863,"twenty":-25.226203,"median":-15.387938,"eighty":-8.690928,"marketCap":1881583598},{"date":"2022-11-11","current":-11.266009,"twenty":-24.885032,"median":-15.309677,"eighty":-8.584128,"marketCap":1663302276},{"date":"2022-11-18","current":-9.768047,"twenty":-24.38737,"median":-15.287456,"eighty":-8.694003,"marketCap":1442144677},{"date":"2022-11-25","current":-9.304889,"twenty":-24.266843,"median":-15.048075,"eighty":-8.868577,"marketCap":1373764472},{"date":"2022-12-02","current":-10.01423,"twenty":-24.249347,"median":-14.98639,"eighty":-8.955101,"marketCap":1478490912},{"date":"2022-12-09","current":-9.03367,"twenty":-24.240599,"median":-14.940941,"eighty":-8.928396,"marketCap":1333722010},{"date":"2022-12-16","current":-8.040592,"twenty":-24.217271,"median":-14.796025,"eighty":-8.868577,"marketCap":1187104994},{"date":"2022-12-23","current":-7.598297,"twenty":-24.13368,"median":-14.591567,"eighty":-8.50262,"marketCap":1121804979},{"date":"2022-12-30","current":-8.073973,"twenty":-24.110352,"median":-14.330392,"eighty":-8.408309,"marketCap":1192033297},{"date":"2023-01-06","current":-8.528786,"twenty":-23.57381,"median":-14.236197,"eighty":-8.324328,"marketCap":1259181426},{"date":"2023-01-13","current":-9.571935,"twenty":-23.377467,"median":-14.199804,"eighty":-8.39652,"marketCap":1413190896},{"date":"2023-01-20","current":-9.008634,"twenty":-23.321092,"median":-14.180537,"eighty":-8.415502,"marketCap":1330025782},{"date":"2023-01-27","current":-9.35496,"twenty":-23.27638,"median":-14.039245,"eighty":-8.43597,"marketCap":1381156926},{"date":"2023-02-03","current":-9.717976,"twenty":-23.258884,"median":-13.951473,"eighty":-8.450775,"marketCap":1434752222},{"date":"2023-02-10","current":-8.532959,"twenty":-23.012969,"median":-13.782352,"eighty":-8.468702,"marketCap":1259797464},{"date":"2023-02-17","current":-8.804177,"twenty":-22.845786,"median":-13.705284,"eighty":-8.481141,"marketCap":1299839926},{"date":"2023-02-24","current":-7.769373,"twenty":-22.723314,"median":-13.652144,"eighty":-8.430746,"marketCap":1147062532},{"date":"2023-03-03","current":-7.649257,"twenty":-22.539607,"median":-13.611089,"eighty":-8.272588,"marketCap":1203893669},{"date":"2023-03-10","current":-6.710288,"twenty":-22.453099,"median":-13.493526,"eighty":-8.148245,"marketCap":1056112166},{"date":"2023-03-17","current":-6.474564,"twenty":-22.305356,"median":-13.247156,"eighty":-8.017637,"marketCap":1019012207},{"date":"2023-03-24","current":-5.665244,"twenty":-22.206212,"median":-13.178651,"eighty":-7.921708,"marketCap":891635681},{"date":"2023-03-31","current":-5.665244,"twenty":-22.088601,"median":-13.157243,"eighty":-7.889544,"marketCap":891635681},{"date":"2023-04-06","current":-5.24094,"twenty":-21.979737,"median":-12.934602,"eighty":-7.787733,"marketCap":824855755},{"date":"2023-04-14","current":-6.164194,"twenty":-21.772702,"median":-12.704975,"eighty":-7.643766,"marketCap":970163927},{"date":"2023-04-21","current":-6.223125,"twenty":-21.728963,"median":-12.641626,"eighty":-7.541049,"marketCap":979438917},{"date":"2023-04-28","current":-6.183837,"twenty":-21.601631,"median":-12.414392,"eighty":-7.449107,"marketCap":973255591},{"date":"2023-05-05","current":-6.416544,"twenty":-21.458748,"median":-12.339465,"eighty":-7.283557,"marketCap":1009880688},{"date":"2023-05-12","current":-7.140422,"twenty":-21.366408,"median":-12.2153,"eighty":-7.056792,"marketCap":1123809594},{"date":"2023-05-19","current":-5.645987,"twenty":-21.353772,"median":-12.005503,"eighty":-6.84703,"marketCap":1011738224},{"date":"2023-05-26","current":-5.484703,"twenty":-21.301528,"median":-11.932716,"eighty":-6.700859,"marketCap":982836796},{"date":"2023-06-02","current":-5.325726,"twenty":-21.108106,"median":-11.766756,"eighty":-6.635642,"marketCap":954348773},{"date":"2023-06-09","current":-6.079138,"twenty":-21.087446,"median":-11.594473,"eighty":-6.416544,"marketCap":1089357231},{"date":"2023-06-16","current":-6.856742,"twenty":-20.922206,"median":-11.547376,"eighty":-6.377203,"marketCap":1228700822},{"date":"2023-06-23","current":-6.44202,"twenty":-20.820883,"median":-11.495572,"eighty":-6.386645,"marketCap":1154384240},{"date":"2023-06-30","current":-6.486948,"twenty":-20.775317,"median":-11.413579,"eighty":-6.384285,"marketCap":1162435203},{"date":"2023-07-07","current":-6.421284,"twenty":-20.723938,"median":-11.293719,"eighty":-6.391554,"marketCap":1150668411},{"date":"2023-07-14","current":-7.036455,"twenty":-20.346101,"median":-11.243385,"eighty":-6.401592,"marketCap":1260904674},{"date":"2023-07-21","current":-6.853286,"twenty":-19.830124,"median":-11.037127,"eighty":-6.413167,"marketCap":1228081517},{"date":"2023-07-28","current":-6.725414,"twenty":-19.745125,"median":-10.451203,"eighty":-6.41844,"marketCap":1205167238},{"date":"2023-08-04","current":-6.538789,"twenty":-19.636542,"median":-10.136105,"eighty":-6.422166,"marketCap":1171724776},{"date":"2023-08-11","current":-5.966628,"twenty":-19.456656,"median":-10.018403,"eighty":-6.401592,"marketCap":1146982734},{"date":"2023-08-18","current":-4.829654,"twenty":-19.292947,"median":-9.773418,"eighty":-6.367993,"marketCap":928418801},{"date":"2023-08-25","current":-4.425249,"twenty":-19.23598,"median":-9.717976,"eighty":-6.300434,"marketCap":850678861},{"date":"2023-09-01","current":-4.266139,"twenty":-19.174195,"median":-9.705786,"eighty":-6.25816,"marketCap":820092654},{"date":"2023-09-08","current":-4.173325,"twenty":-19.114826,"median":-9.685396,"eighty":-6.236766,"marketCap":802250701},{"date":"2023-09-15","current":-4.279398,"twenty":-19.0229,"median":-9.601139,"eighty":-6.205112,"marketCap":822641505},{"date":"2023-09-22","current":-4.126917,"twenty":-18.777764,"median":-9.571935,"eighty":-6.17598,"marketCap":793329724},{"date":"2023-09-29","current":-4.295972,"twenty":-18.642748,"median":-9.496828,"eighty":-6.102833,"marketCap":825827568},{"date":"2023-10-06","current":-4.00427,"twenty":-18.530714,"median":-9.463447,"eighty":-6.065314,"marketCap":769752857},{"date":"2023-10-13","current":-3.815327,"twenty":-18.44166,"median":-9.432153,"eighty":-6.005773,"marketCap":733431737},{"date":"2023-10-20","current":-3.193803,"twenty":-18.423467,"median":-9.417549,"eighty":-5.961324,"marketCap":613954369},{"date":"2023-10-23","current":-3.076128,"twenty":-18.409103,"median":-9.417549,"eighty":-5.948537,"marketCap":591333320},{"date":"2023-11-02","current":-3.894882,"twenty":-18.366013,"median":-9.409204,"eighty":-5.912754,"marketCap":748724840},{"date":"2023-11-10","current":-5.303884,"twenty":-18.188865,"median":-9.371259,"eighty":-5.806678,"marketCap":1022594077},{"date":"2023-11-17","current":-3.630713,"twenty":-18.181204,"median":-9.354906,"eighty":-5.783302,"marketCap":700005173},{"date":"2023-11-24","current":-4.007673,"twenty":-18.177374,"median":-9.354852,"eighty":-5.751026,"marketCap":772683305},{"date":"2023-12-01","current":-4.594669,"twenty":-18.15535,"median":-9.317619,"eighty":-5.676693,"marketCap":885856819},{"date":"2023-12-08","current":-5.385214,"twenty":-18.119031,"median":-9.225609,"eighty":-5.662887,"marketCap":1038274679},{"date":"2023-12-15","current":-5.973375,"twenty":-17.983092,"median":-9.196401,"eighty":-5.647293,"marketCap":1151672610},{"date":"2023-12-22","current":-5.877434,"twenty":-17.786329,"median":-9.112949,"eighty":-5.647293,"marketCap":1133175075},{"date":"2023-12-29","current":-6.23617,"twenty":-17.771426,"median":-9.090397,"eighty":-5.647529,"marketCap":1202339771},{"date":"2024-01-05","current":-5.677209,"twenty":-17.741404,"median":-9.083741,"eighty":-5.647372,"marketCap":1094571524},{"date":"2024-01-12","current":-5.426928,"twenty":-17.703407,"median":-9.07331,"eighty":-5.646676,"marketCap":1046317085},{"date":"2024-01-19","current":-5.139104,"twenty":-17.687994,"median":-9.060792,"eighty":-5.637742,"marketCap":990824480},{"date":"2024-01-26","current":-4.943051,"twenty":-17.67943,"median":-9.008634,"eighty":-5.556573,"marketCap":953025170},{"date":"2024-02-02","current":-4.676085,"twenty":-17.646476,"median":-8.931885,"eighty":-5.540349,"marketCap":901553768},{"date":"2024-02-09","current":-4.926366,"twenty":-17.600923,"median":-8.854204,"eighty":-5.489345,"marketCap":949808207},{"date":"2024-02-16","current":-5.539554,"twenty":-17.558087,"median":-8.808349,"eighty":-5.424425,"marketCap":1068031583},{"date":"2024-02-23","current":-5.55624,"twenty":-17.501847,"median":-8.739502,"eighty":-5.431099,"marketCap":1071248545},{"date":"2024-03-01","current":-7.126121,"twenty":-17.490421,"median":-8.587202,"eighty":-5.450287,"marketCap":1425708706},{"date":"2024-03-08","current":-6.244237,"twenty":-17.443314,"median":-8.530873,"eighty":-5.463635,"marketCap":1249272028},{"date":"2024-03-15","current":-5.684178,"twenty":-17.398877,"median":-8.482756,"eighty":-5.478528,"marketCap":1137222194},{"date":"2024-03-22","current":-5.521176,"twenty":-17.391734,"median":-8.450048,"eighty":-5.478528,"marketCap":1104610675},{"date":"2024-03-28","current":-5.512817,"twenty":-17.363164,"median":-8.414303,"eighty":-5.460298,"marketCap":1102938290},{"date":"2024-04-05","current":-3.627843,"twenty":-17.31036,"median":-8.345192,"eighty":-5.426928,"marketCap":725815341},{"date":"2024-04-12","current":-3.372891,"twenty":-17.293545,"median":-8.200132,"eighty":-5.385214,"marketCap":674807581},{"date":"2024-04-19","current":-2.783576,"twenty":-17.276708,"median":-8.144907,"eighty":-5.349918,"marketCap":556904398},{"date":"2024-04-26","current":-2.609113,"twenty":-17.156631,"median":-8.037593,"eighty":-5.335158,"marketCap":521999934},{"date":"2024-05-03","current":-2.57975,"twenty":-17.130534,"median":-7.969658,"eighty":-5.31947,"marketCap":516125336},{"date":"2024-05-10","current":-2.713119,"twenty":-17.058943,"median":-7.92205,"eighty":-5.252726,"marketCap":534020535},{"date":"2024-05-17","current":-2.721651,"twenty":-17.039792,"median":-7.898724,"eighty":-5.220173,"marketCap":535699845},{"date":"2024-05-24","current":-2.27373,"twenty":-17.035004,"median":-7.879511,"eighty":-5.172475,"marketCap":447536077},{"date":"2024-05-31","current":-2.192678,"twenty":-17.023514,"median":-7.815272,"eighty":-5.164385,"marketCap":431582634},{"date":"2024-06-07","current":-2.252401,"twenty":-17.00915,"median":-7.649257,"eighty":-5.113676,"marketCap":443337803},{"date":"2024-06-14","current":-2.38891,"twenty":-16.914933,"median":-7.642959,"eighty":-5.054805,"marketCap":470206760},{"date":"2024-06-21","current":-2.188412,"twenty":-16.853315,"median":-7.598297,"eighty":-5.000761,"marketCap":430742979},{"date":"2024-06-28","current":-2.030573,"twenty":-16.852593,"median":-7.589952,"eighty":-4.980279,"marketCap":399675746},{"date":"2024-07-05","current":-2.192678,"twenty":-16.829112,"median":-7.514845,"eighty":-4.961403,"marketCap":431582634},{"date":"2024-07-12","current":-2.717385,"twenty":-16.795715,"median":-7.475676,"eighty":-4.926252,"marketCap":534860190},{"date":"2024-07-15","current":-2.870958,"twenty":-16.789721,"median":-7.453197,"eighty":-4.924469,"marketCap":565087767},{"date":"2024-08-02","current":-2.870958,"twenty":-16.783727,"median":-7.450641,"eighty":-4.918023,"marketCap":565087767},{"date":"2024-08-09","current":-2.389593,"twenty":-16.740912,"median":-7.389961,"eighty":-4.826532,"marketCap":460357437},{"date":"2024-08-16","current":-1.994256,"twenty":-16.733959,"median":-7.296883,"eighty":-4.801708,"marketCap":384195361},{"date":"2024-08-23","current":-2.126035,"twenty":-16.609079,"median":-7.195432,"eighty":-4.755606,"marketCap":409582720},{"date":"2024-08-30","current":-2.692685,"twenty":-16.561048,"median":-7.149294,"eighty":-4.718312,"marketCap":518748362},{"date":"2024-09-06","current":-2.429126,"twenty":-16.511096,"median":-7.124489,"eighty":-4.649992,"marketCap":467973645},{"date":"2024-09-13","current":-2.481838,"twenty":-16.497212,"median":-7.057192,"eighty":-4.594267,"marketCap":478128588},{"date":"2024-09-20","current":-2.363237,"twenty":-16.471361,"median":-7.034442,"eighty":-4.512568,"marketCap":455279966},{"date":"2024-09-27","current":-2.178746,"twenty":-16.434247,"median":-7.001895,"eighty":-4.45243,"marketCap":419737663},{"date":"2024-10-04","current":-2.073323,"twenty":-16.227702,"median":-6.929319,"eighty":-4.356537,"marketCap":399427776},{"date":"2024-10-11","current":-2.020612,"twenty":-16.165511,"median":-6.877479,"eighty":-4.305916,"marketCap":389272833},{"date":"2024-10-18","current":-2.398378,"twenty":-16.152523,"median":-6.863399,"eighty":-4.276746,"marketCap":462049928},{"date":"2024-10-25","current":-2.512587,"twenty":-16.102288,"median":-6.853286,"eighty":-4.248902,"marketCap":484052305},{"date":"2024-10-31","current":-2.543335,"twenty":-16.064409,"median":-6.836006,"eighty":-4.196586,"marketCap":489976022},{"date":"2024-11-08","current":-2.732949,"twenty":-16.036586,"median":-6.820277,"eighty":-4.165088,"marketCap":538462022},{"date":"2024-11-15","current":-2.311834,"twenty":-15.910413,"median":-6.725414,"eighty":-4.125591,"marketCap":455491459},{"date":"2024-11-22","current":-1.976661,"twenty":-15.804065,"median":-6.707483,"eighty":-4.019554,"marketCap":389453664},{"date":"2024-11-29","current":-2.410667,"twenty":-15.740665,"median":-6.694678,"eighty":-3.996315,"marketCap":474964142},{"date":"2024-12-06","current":-2.625522,"twenty":-15.671678,"median":-6.665887,"eighty":-3.89886,"marketCap":517296062},{"date":"2024-12-13","current":-2.677087,"twenty":-15.659751,"median":-6.628019,"eighty":-3.827586,"marketCap":527455723},{"date":"2024-12-20","current":-2.217298,"twenty":-15.603312,"median":-6.573349,"eighty":-3.714001,"marketCap":436865414},{"date":"2024-12-27","current":-2.707167,"twenty":-15.538951,"median":-6.557068,"eighty":-3.628417,"marketCap":533382192},{"date":"2025-01-03","current":-2.582551,"twenty":-15.523581,"median":-6.538789,"eighty":-3.560971,"marketCap":508829678},{"date":"2025-01-10","current":-2.582551,"twenty":-15.432193,"median":-6.474564,"eighty":-3.367876,"marketCap":508829678},{"date":"2025-01-17","current":-2.621225,"twenty":-15.409346,"median":-6.432755,"eighty":-3.08703,"marketCap":516449424},{"date":"2025-01-24","current":-3.433375,"twenty":-15.404208,"median":-6.418914,"eighty":-3.076481,"marketCap":676464081},{"date":"2025-01-31","current":-3.184143,"twenty":-15.393076,"median":-6.395376,"eighty":-3.084451,"marketCap":627359054},{"date":"2025-02-07","current":-3.592367,"twenty":-15.377104,"median":-6.374177,"eighty":-3.105077,"marketCap":707789702},{"date":"2025-02-14","current":-3.313056,"twenty":-15.338182,"median":-6.353599,"eighty":-3.152028,"marketCap":652758206},{"date":"2025-02-21","current":-3.364621,"twenty":-15.311151,"median":-6.327828,"eighty":-3.179529,"marketCap":662917867},{"date":"2025-02-28","current":-2.641631,"twenty":-15.302306,"median":-6.296207,"eighty":-3.081873,"marketCap":524915808},{"date":"2025-03-07","current":-2.953767,"twenty":-15.296366,"median":-6.267048,"eighty":-3.015698,"marketCap":586940026},{"date":"2025-03-14","current":-2.74821,"twenty":-15.283923,"median":-6.253996,"eighty":-2.947346,"marketCap":546093973},{"date":"2025-03-21","current":-2.475623,"twenty":-15.186404,"median":-6.244237,"eighty":-2.887812,"marketCap":491928554},{"date":"2025-03-28","current":-2.359438,"twenty":-15.04039,"median":-6.236318,"eighty":-2.869701,"marketCap":468841655},{"date":"2025-04-04","current":-1.71819,"twenty":-15.021782,"median":-6.213689,"eighty":-2.823583,"marketCap":341419727},{"date":"2025-04-11","current":-1.362933,"twenty":-14.991344,"median":-6.203518,"eighty":-2.777216,"marketCap":270827092},{"date":"2025-04-17","current":-2.015354,"twenty":-14.957484,"median":-6.183646,"eighty":-2.758732,"marketCap":400468913},{"date":"2025-04-25","current":-2.58287,"twenty":-14.940941,"median":-6.17598,"eighty":-2.754435,"marketCap":513239539},{"date":"2025-05-02","current":-2.457748,"twenty":-14.939571,"median":-6.102709,"eighty":-2.742876,"marketCap":488376724},{"date":"2025-05-09","current":-2.009782,"twenty":-14.916543,"median":-6.061858,"eighty":-2.718238,"marketCap":399361701},{"date":"2025-05-16","current":-2.127547,"twenty":-14.826217,"median":-6.0325,"eighty":-2.708026,"marketCap":385098783},{"date":"2025-05-23","current":-2.157096,"twenty":-14.73221,"median":-5.999528,"eighty":-2.689408,"marketCap":390447378},{"date":"2025-05-30","current":-2.265444,"twenty":-14.678238,"median":-5.993269,"eighty":-2.679507,"marketCap":410058890},{"date":"2025-06-06","current":-2.821955,"twenty":-14.591567,"median":-5.970002,"eighty":-2.670721,"marketCap":510790748}],"updateTime":1749408230244}}}